. Author manuscript; available in PMC: 2014 Jun 24.

Published in final edited form as: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006826. doi: 10.1002/14651858.CD006826

Analysis 2.24. Comparison 2 Fluticasone/salmeterol (FPS) versus fluticasone (FP), Outcome 24 Withdrawals due to adverse events.

Review: Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease

Comparison: 2 Fluticasone/salmeterol (FPS) versus fluticasone (FP)

Outcome: 24 Withdrawals due to adverse events